More Information »FMS-like receptor tyrosine kinase-3 (FLT3) is a member of the class III RTK (receptor tyrosine kinase) family and is expressed primarily in hematopoietic progenitor cells. Its expression in these cells means that FLT3 has an important role in the pathogenesis of AML.
Product Name / Activity
|Potent FLT3 inhibitor; also inhibits other PDGFR family members|
|Potent and selective FLT3 inhibitor|
|FLT3 inhibitor; displays antiproliferative activity|
|Potent FLT3 inhibtor; also inhibits of MET, VEGFR2, Ron and AXL|
|PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor; antiangiogenic|
|FLT3, JAK2 and TrkA inhibitor; also inhibits AurA and AurB|
|Inhbitor of VEGFR, KIT, RET, MET and FLT3|
|Potent FLT3 inhibitor|
|Potent FLT3 inhibitor; also inhibits other RTKs|
Find multiple products by catalog number
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.